CompoAtlas

Swissmed Whitomato Forte Capsule

Natural health product licensed in Canada

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Solanum lycopersicum

Source : Solanum lycopersicum - fruit

Extract : Matériel brut frais

Extraction ratio : 500:1

Dry plant equivalent : 100,000 mg

200 mgNot calculated
L-Glutathione

Source : Glutathione

245 mgNot calculated
L-Glutathione

Source : Saccharomyces cerevisiae - en entier

245 mgNot calculated
Acide hyaluronique

Source : Streptococcus equi - capsule extracellulaire bactérienne

20 mgNot calculated
Acide hyaluronique

Source : Hyaluronate de sodium

20 mgNot calculated
3,3'-Dihydroxy-bêta, bêta-carotène-4,4'-diène

Source : Haematococcus pluvialis - whole

5 mgNot calculated

Non-medicinal ingredients

Ascorbate de sodium, Dioxyde de titane, Amidon alimentaire, modifié, Amidon de riz, Mannitol, Sucre, Acide stéarique, Stéarate de magnésium, Palmitate d'ascorbyle, Rouge 40, Cellulose microcristalline, Amidon de maïs modifié, Gélatine, Hydroxypropylméthylcellulose

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years1 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Source of (an) antioxidant(s)/Provides (an) antioxidant(s). Source of/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Product record

Licence holder
NuEra Nutraceutical Inc.
NPN or DIN-HM
80132692
Status
Active licence
Licence date
22 July 2024
Revision date
Not provided
Form
Capsule, dur
Route of administration
Orale
Application type
Générale (non traditionelle)

Source

Official Health Canada record, licence 80132692

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Swissmed Whitomato Forte Capsule (NuEra Nutraceutical Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80132692-swissmed-whitomato-forte-capsule, updated 22 July 2024.

Enter to analyse, Shift+Enter for a new line